Skip to content

Member

Marie-Luce BRASIER-CLAIN

Patriots · France

Group
Patriots PfE
Country
France
Roll-call participation
99.9 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
92.2 %ⓘ of 5 902 votes where the group had a line · Patriots median 82.7 %
More facts (5)
National party
RN Rassemblement national
In office
Since 16 Jul 2024
Against clear line
36 of 4 690 votesⓘ
Committees
ENVI, REGI (substitute), SANT (substitute)
Member id
256878
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

99.9 %

5 923 of 5 928 roll calls while in office

Patriots median: 91.1 % (+8.8 pts)

Chamber median: 90.2 %

With majority line ⓘ

92.2 %

5 440 of 5 902 votes where their group had a line

Patriots median: 82.7 % (+9.5 pts)

Against clear line ⓘ

0.8 %

36 of 4 690 votes where their group had a clear line

13 opposite (for ↔ against), 23 abstained against the line

Abstention ⓘ

11.4 %

674 of 5 923 votes cast

Participation 99.9 % — Patriots median 91.1 %, 89 members.ⓘ
Data as a table
Participation among the 89 members of the Patriots with enough votes.
FigureParticipation
Marie-Luce BRASIER-CLAIN99.9 %
Patriots median91.1 %
Lowest in the group44.5 %
Highest in the group99.9 %
Members89
With majority line 92.2 % — Patriots median 82.7 %, 89 members.ⓘ
Data as a table
With majority line among the 89 members of the Patriots with enough votes.
FigureWith majority line
Marie-Luce BRASIER-CLAIN92.2 %
Patriots median82.7 %
Lowest in the group72.5 %
Highest in the group92.9 %
Members89
  • Whole term, 5 928 roll-call votes. The dots are the other members of Patriots; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: Abstained Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: Against Majority line: Against
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: For Majority line: Tie
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: For Majority line: For
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 0 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202422
18 Sept 202422
19 Sept 20249292
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202422
22 Oct 20241010
23 Oct 2024129129
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202422
26 Nov 20241818
27 Nov 20241111
28 Nov 20245757
17 Dec 20241313
18 Dec 20243333
19 Dec 20244544
20 Jan 202522
21 Jan 202511
22 Jan 202522
23 Jan 20254545
10 Feb 202511
11 Feb 20253232
12 Feb 20251010
13 Feb 20253030
10 Mar 202522
11 Mar 202599
12 Mar 2025228228
13 Mar 20252424
31 Mar 202533
1 Apr 20253535
2 Apr 2025251251
3 Apr 20256262
5 May 202555
6 May 20251010
7 May 2025220219
8 May 2025103103
21 May 202522
22 May 20255353
16 Jun 202522
17 Jun 20254141
18 Jun 20259191
19 Jun 20258787
7 Jul 202511
8 Jul 20255555
9 Jul 2025134134
10 Jul 20253636
8 Sept 202511
9 Sept 2025101101
10 Sept 20253434
11 Sept 20256969
6 Oct 202522
7 Oct 202555
8 Oct 20255554
9 Oct 20256565
20 Oct 202533
21 Oct 20251313
22 Oct 2025186186
23 Oct 20255555
13 Nov 2025267267
24 Nov 202533
25 Nov 20257575
26 Nov 2025100100
27 Nov 2025125125
15 Dec 202544
16 Dec 20256666
17 Dec 20254343
18 Dec 20254242
20 Jan 20266767
21 Jan 2026112112
22 Jan 20265858
9 Feb 202622
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141141
24 Feb 20264343
9 Mar 202611
10 Mar 2026197197
11 Mar 20266060
12 Mar 20263434
25 Mar 202633
26 Mar 20266969
27 Apr 202622
28 Apr 2026225225
29 Apr 2026296296
30 Apr 20266868
18 May 202644
19 May 202633
20 May 20269696
21 May 20269898
15 Jun 202622
16 Jun 20264040
17 Jun 2026127125
18 Jun 20267777
6 Jul 202622
7 Jul 20267272
8 Jul 2026144144
9 Jul 20266767
14 Sept 202611
15 Sept 2026155155
16 Sept 20268080
17 Sept 2026124124

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within Patriots

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Séverine WERBROUCK PatriotsFrance100 % of 5 098 shared74 %
Julien LEONARDELLI PatriotsFrance100 % of 5 528 shared74 %
Jean-Paul GARRAUD PatriotsFrance100 % of 5 398 shared74 %
Valérie DELOGE PatriotsFrance100 % of 5 776 shared74 %
Marie DAUCHY PatriotsFrance100 % of 4 518 shared74 %
Anne-Sophie FRIGOUT PatriotsFrance100 % of 5 278 shared74 %
Gilles PENNELLE PatriotsFrance100 % of 5 788 shared74 %
Pierre-Romain THIONNET PatriotsFrance100 % of 5 520 shared74 %
André ROUGÉ PatriotsFrance100 % of 5 731 shared74 %
Fabrice LEGGERI PatriotsFrance100 % of 5 556 shared74 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Sarah KNAFO ESNFrance78 % of 4 440 shared70 %
Guillaume PELTIER ECRFrance78 % of 5 118 shared68 %
Laurence TROCHU ECRFrance76 % of 5 678 shared68 %
Nicolas BAY ECRFrance76 % of 5 344 shared68 %
Marion MARÉCHAL ECRFrance76 % of 5 074 shared68 %
Luis-Vicențiu LAZARUS No groupRomania73 % of 4 909 shared51 %
Volker SCHNURRBUSCH changed group ESNGermany71 % of 4 571 shared69 %
René AUST ESNGermany70 % of 5 402 shared70 %
Hans NEUHOFF ESNGermany70 % of 4 437 shared70 %
Marc JONGEN ESNGermany70 % of 5 286 shared70 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember22 Jan 2026now
Committee on Regional DevelopmentREGI CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeSubstitute22 Jan 2026now
Delegation to the EU-Moldova Parliamentary Association CommitteeD-MD DelegationSubstitute7 Nov 2024now
Delegation for relations with South AfricaD-ZA DelegationMember19 Sept 2024now
Delegation to the OACPS-EU Joint Parliamentary AssemblyDACP Parliamentary assemblySubstitute19 Sept 2024now
Delegation to the Africa-EU Parliamentary AssemblyDAFR Parliamentary assemblySubstitute19 Sept 2024now
Delegation to the Euronest Parliamentary AssemblyDEPA Parliamentary assemblyMember13 Nov 2024now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Christians in the Middle EastIG10-07 Intergroup / working groupMember20 Feb 2025now

Show all 16 seats

Dossiers

No rapporteur, shadow or negotiator role recorded this term.

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

20 contributions recorded; 5 on behalf of their group; 26 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) Speech · 1 minRead
8 Jul 2026Harnessing the potential of a competitive and sustainable EU Bioeconomy Strategy for EU strategic autonomy (debate) on behalf of PatriotsSpeech · 1 minRead
17 Jun 2026Protecting children’s safety and mental health from the risks posed by social media – our duty to act now (debate) Speech · 1 minRead
21 May 2026The Union’s preparedness for and response to health emergencies: the case of the MV Hondius and the hantavirus warning (debate) Speech · 1 minRead
30 Apr 2026Women’s entrepreneurship in rural and island areas and outermost regions (debate) on behalf of PatriotsSpeech · 1 minRead
12 Mar 2026Prevention and treatment of obesity (debate) Speech · 2 minRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) Speech · 2 minRead
15 Dec 2025Impact of the geopolitical situation on European patients and their access to medicines (debate) on behalf of PatriotsSpeech · 1 minRead
27 Nov 2025Outcome of the UN Climate Change Conference - Belém (COP30) (debate) Speech · 1 minRead
23 Oct 2025Breast cancer: the importance of screening (debate) Speech · 1 minRead

Show all 20 recent contributions

Questions and motions, 130

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
9 Sept 2026The 28th regime/EU Inc.: can the Commission guarantee the soundness of its legal basis? P-10-2026-003589Priority written questionwith 17 co-authorsNot yet answered
7 Sept 2026Financing alternatives to Canadair E-10-2026-003520Written questionwith 5 co-authorsNot yet answered
2 Sept 2026Adhering to the timeline for the European Disability Card E-10-2026-003450Written questionwith 10 co-authorsNot yet answered
10 Aug 2026Putting an end to AdBlue-related fire engine breakdowns E-10-2026-003245Written questionwith 13 co-authorsNot yet answered
23 Jul 2026MOTION FOR A RESOLUTION on the spread of Sargassum and its impact on the outermost regions, notably Guadeloupe and Martinique B-10-2026-0372Motion for a resolutionwith 15 co-authors—
17 Jul 2026Adapting EU energy performance policies in the light of extreme heat episodes O-10-2026-000032Oral questionwith 35 co-authorsNot yet answered
17 Jul 2026Reshoring of the flax sector: industrial and strategic challenges for the EU E-10-2026-003046Written questionwith 8 co-authors3 Sept 2026
15 Jul 2026Commission’s ‘anti-racism’ strategy: towards a presumption that European societies are racist? E-10-2026-002952Written questionwith 11 co-authors21 Aug 2026
14 Jul 2026PPWR Regulation: simplification or yet another mess of red tape? E-10-2026-002900Written questionwith 8 co-authors1 Sept 2026
13 Jul 2026Taking account of the outermost regions’ specific characteristics in the revision of State aid for air transport E-10-2026-002871Written questionwith 10 co-authors2 Sept 2026

Show all 130 questions and motions

Amendments tabled in committee, 151

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
16 Sept 2026Establishing the European Fund for Regional Development including for European Territorial Cooperation (Interreg) and the Cohesion Fund as part of the Fund set out in Regulation (EU) […] [NRP] and establishing conditions for the implementation of the Union support to regional development from 2028 to 2034 REGI-AM-792057 REGI24
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT8
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT9
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ6423
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ6417
7 Sept 2026Establishing the European Fund for Regional Development including for European Territorial Cooperation (Interreg) and the Cohesion Fund as part of the Fund set out in Regulation (EU) […] [NRP] and establishing conditions for the implementation of the Union support to regional development from 2028 to 2034 REGI-AM-792058 REGI66
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT24
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT26
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT20
23 Jul 2026Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for the acceleration of industrial capacity and decarbonisation in strategic sectors and amending Regulations (EU) 2018/1724, (EU) 2024/1735 and (EU) 2024/3110 ENVI-AM-791125 ENVI20

Show all 151 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation France National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Marie-Luce BRASIER-CLAIN”. Member record. memberId 256878. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256878?page=4&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256878. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256878?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-256878,
  author = {{EU Parl Watch Research}},
  title = {{Marie-Luce BRASIER-CLAIN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256878?page=4&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/256878?page=4&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256878. Official source: https://www.europarl.europa.eu/meps/en/256878. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}